Patient Preference and Time Allocation Associated with Transition from Intravenous to Subcutaneous Administration of Natalizumab (Tysabri) in Patients with Relapsing Remitting MS – A Questionnaire Study
Anna Almroth, Karin Söderbärg, Irina Sjöblom · 2025
Read Patient Preference and Time Allocation Associated with Transition from Intravenous to Subcutaneous Administration of Natalizumab (Tysabri) in Patients with Relapsing Remitting MS – A Questionnaire Study by Anna Almroth, Karin Söderbärg, Irina Sjöblom (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12743484.txt.
Description
Anna Almroth, Karin Soderbarg, and Irina Sjoblom survey patients and staff on a switch in how a multiple sclerosis drug is given. Their 2025 study covers eighty-three patients and fourteen staff at five Swedish hospitals. All had known both drip dosing in hospital and skin shots, which can move to local clinics.
Shots took far less time: most patients spent half an hour or less, against one to two hours for drips. In local clinics most shots wrapped in under fifteen minutes. Four in five patients favored shots, and staff found prep quicker with smoother flow. Work life suffered less with clinic shots. Both sides called the switch easy to handle.
Catalog record
| CREATOR | Anna Almroth, Karin Söderbärg, Irina Sjöblom |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |